|Articles|December 3, 2012

AHIP's Fall Forum 2012 Slideshow

Check out photos from America's Health Insurance Plans Fall Forum 2012. The meeting is being held at the Renaissance Hotel in Chicago, IL, from December 3-5.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

ByBrooke McCormick,Xavier Leleu, MD, PhD

July 28th 2026

Leukemiaonwoodenblocks| Image Credit: © bo-stock.adobe.com

Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLL

ByMaggie L. Shaw

July 22nd 2026

Rahul Banerjee, MD, FACP | Image Credit: © Fred Hutch Cancer Center

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD

ByBrooke McCormick,Rahul Banerjee, MD

July 21st 2026

Dr Claire Harrison | Image Credit: Guy's and St. Thomas' NHS Foundation Trust

Early Data Support INCA033989 in CALR-Mutant Myelofibrosis: Claire Harrison, MD

ByBrooke McCormick,Claire Harrison, MD

July 17th 2026

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

ByBrooke McCormick,Claire Harrison, MD

July 12th 2026

AHIP's Fall Forum 2012 Slideshow

Related Content

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLL

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD

Early Data Support INCA033989 in CALR-Mutant Myelofibrosis: Claire Harrison, MD

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

Trending on AJMC

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

New MINT Trial Analysis Favors Liberal Transfusion After MI

Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale

Nipocalimab Improves gMG Outcomes Across East Asian Subgroup

Drug Development-to-Reimbursement Timelines Show Little Progress Over a Decade